Dialybrid
Dialybrid is a Cantù-based company in medical devices, listed in Section 1 of the Raise Track Update of 2026-09-24.
- Industry
- medical devices
- Location
- Cantù, Italy
About
Dialybrid is listed in Section 1 of the Raise Track Update of 2026-09-24, which gives the round as $3M (Series A). Investors named in the issue: not disclosed in the issue. The issue describes the company this way: S.r.l., a Cantù, Italy-based medical device company developing a novel vascular access solution for hemodialysis based on Silkothane®, a patented hybrid material made up of silk fibroin and polyurethane closed a €15m series A funding round The round was led by new investor XGEN Venture, with participation of CDP Venture Capital (Rilancio Fund).
The issue lists the amount as $3M, but its description says the company closed a €15m Series A, so no amount is shown until a second source settles it.
This page is not indexed by search engines yet. It is promoted once a second source, separate from the newsletter, confirms the round.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Series A 2026 | 2026-09-24 |
Sources
Last verified:
- https://www.finsmes.com/2026/09/dialybrid-raises-e15m-in-series-a-funding-2.html
Type: reputable publication. Accessed 2026-10-12.
Article linked from the Raise Track Update for 2026-09-24. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-09-24/
Type: other verified public source. Accessed 2026-10-12.
Raise Track Update for 2026-09-24, Section 1. Lists Dialybrid at $3M (Series A) with investors: undisclosed.